EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma

Guo Li, Lu Chen, Hua Bai, Li Zhang, Jie Wang, Weimin Li

Precision Clinical Medicine · 01.05.2024 · 7 (2)

DOI: 10.1093/pcmedi/pbae011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Clinical Medicine, online erschienen am 08.05.2024. Verfasst von Guo Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Ca…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Project of Sichuan, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung squamous cell carcinoma (LUSC) lacks effective targeted therapies and has a poor prognosis. Disruption of squalene epoxidase (SQLE) has been implicated in metabolic disorders and cancer. However, the role of SQLE as a monooxygenase involved in oxidative stress remains unclear.

Methods

We analyzed the expression and prognosis of lung adenocarcinoma (LUAD) and LUSC samples from GEO and TCGA databases. The proliferative activity of the tumors after intervention of SQLE was verified by cell and animal experiments. JC-1 assay, flow cytometry, and Western blot were used to show changes in apoptosis after intervention of SQLE. Flow cytometry and fluorescence assay of ROS levels were used to indicate oxidative stress status.

Results

We investigated the unique role of SQLE expression in the diagnosis and prognosis prediction of LUSC. Knockdown of SQLE or treatment with the SQLE inhibitor terbinafine can suppress the proliferation of LUSC cells by inducing apoptosis and reactive oxygen species accumulation. However, depletion of SQLE also results in the impairment of lipid peroxidation and ferroptosis resistance such as upregulation of glutathione peroxidase 4. Therefore, prevention of SQLE in synergy with glutathione peroxidase 4 inhibitor RSL3 effectively mitigates the proliferation and growth of LUSC.

Conclusion

Our study indicates that the low expression of SQLE employs adaptive survival through regulating the balance of apoptosis and ferroptosis resistance. In future, the combinational therapy of targeting SQLE and ferroptosis could be a promising approach in treating LUSC.

Schlagwörter

Stichwörter der Autor:innen

ROSferroptosislung squamous cell carcinomasqualene epoxidaseterbinafine

Autor:innen und Institutionen

  • CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospit…
  • Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Chengdu 610041, China.
  • The Research Units of West China, Chinese Academy of Medical Sciences, West China Hospital, Chengdu 610041, China.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Project of Sichuan
  • West China Hospital, Sichuan University
  • National Key Research and Development Program of China
  • CAMS Innovation Fund for Medical Sciences
  • CAMS Key Laboratory of Translational Research on Lung Cancer
  • Aiyou foundation

Zitieren

APA

Li, G., Chen, L., Bai, H., Zhang, L., Wang, J., & Li, W. (2024). Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma. Precision Clinical Medicine, 7(2). https://doi.org/10.1093/pcmedi/pbae011

Vancouver

Li G, Chen L, Bai H, Zhang L, Wang J, Li W. Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma. Precision Clinical Medicine. 2024;7(2). doi:10.1093/pcmedi/pbae011

BibTeX
@article{Li2024,
  author = {Li, Guo and Chen, Lu and Bai, Hua and Zhang, Li and Wang, Jie and Li, Weimin},
  title = {Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma},
  journal = {Precision Clinical Medicine},
  year = {2024},
  volume = {7},
  number = {2},
  doi = {10.1093/pcmedi/pbae011}
}
Kostenlos starten →